Posts Tagged ‘Primary’

Circadin Is Approved In The EU For Treatment Of Primary Insomnia In Patients Aged 55 Or Over For Up To 3 Months

Circadin Is Approved In The EU For Treatment Of Primary Insomnia In Patients Aged 55 Or Over For Up To 3 Months
Neurim Pharmaceuticals confirmed that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in patients who are aged 55 or over. The approval was based primarily on data obtained in the latest SOUNDER-SLEEP Phase IV clinical study, indicating that Circadin was safe and more …
Read more on Medical News Today

Tart cherry juice could help reduce severity of insomnia in older adults: Study
Drinking tart cherry juice daily could help reduce the severity of insomnia and time spent awake after going to sleep, according to a new study published in the Journal of Medicinal Food.
Read more on News-Medical-Net

Alexza Offers Pipeline Update
Alexza is developing AZ-007 for the treatment of insomnia in patients who have difficulty falling asleep, including those patients who awake in the middle of the night and have difficulty falling back asleep.
Read more on Zacks.com via Yahoo! Finance

Sleep Apnea: Recognition and Management in Primary Care/Graft Versus Host Disease/Psoriasis in the Patient with HIV Disease

Sleep Apnea: Recognition and Management in Primary Care/Graft Versus Host Disease/Psoriasis in the Patient with HIV Disease

Sleep Apnea: Recognition and Management in Primary Care/Graft Versus Host Disease/Psoriasis in the Patient with HIV Disease

Sleep Apnea: Recognition and Management in Primary Care/Graft Versus Host Disease/Psoriasis in the Patient with HIV Disease